Smart hydrogel with oxygen-scavenging capability inhibits tumor growth and metastasis

The development of various hypoxia-activated prodrugs (HAPs) has made considerable advances in the last few decades; however, cancer therapy using HAPs is still hindered by problems such as poor therapeutic outcomes due to difficulty in reaching the hypoxic region and metastasis resulting from hypoxia.

Leave A Comment

Your email address will not be published. Required fields are marked *